Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma | Zendy

Bingyan Liu | Zendy; Yiping Jia | Zendy; Yan Cao | Zendy; Shaoqiu Wu | Zendy; Haosheng Jiang | Zendy; Xianjun Sun | Zendy; Jun Ma | Zendy; Xiang Yin | Zendy; Aiwu Mao | Zendy; Mingyi Shang | Zendy

Open Access

Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma

Author(s) -

Bingyan Liu,

Yiping Jia,

Yan Cao,

Shaoqiu Wu,

Haosheng Jiang,

Xianjun Sun,

Jun Ma,

Xiang Yin,

Aiwu Mao,

Mingyi Shang

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000445633

Subject(s) - cancer research , carcinogenesis , immunohistochemistry , surgical oncology , medicine , esophageal cancer , pathology , matrigel , metastasis , cancer , oncology , angiogenesis

Phosphoserine aminotransferase 1 (PSAT1) is over-expressed in many carcinoma tissues, however little is known regarding its expression and function in esophageal carcinogenesis. This study investigated the expression of PSAT1 in human esophageal squamous cell carcinoma (ESCC) tissues to determine the relationship between PSAT1 expression and clinicopathological factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research